Literature DB >> 9657173

Transurethral collagen injection for female stress incontinence.

R Elsergany1, A N Elgamasy, G M Ghoniem.   

Abstract

Periurethral collagen injections have been used to treat female urinary incontinence secondary to intrinsic sphincteric deficiency (ISD). As an alternative, a transurethral submucosal collagen injection was used in 33 consecutive women suffering from stress incontinence secondary to ISD at Tulane University Medical Center. Prior to the procedure, careful clinical examination with a videofluorourodynamic study was performed for each case. The procedure was carried out under local anesthesia assisted with monitored anesthesia care (MAC). The collagen was injected transurethrally by the long collagen needle (C. R. Bard). In the first 11 cases the average cumulative collagen injected per patient was 6.1 ml, whereas in the last 22 cases the average was 3.5 ml. As a result of the injection 16 patients were dry (48.5%) and 11 were improved (33.3%), with an overall success rate of 81.8%. The injection failed in 6 patients (18.1%). The mean follow-up was 18.8 months, with a range of 2-33 months. In the successful group there was a significant decrease in pretreatment frequency, from an average of 8 to 4.9 (P = 0.005) and in nocturia from an average of 2.14 to 0.76 (P = 0.001). Also, there was a significant decrease in the number of pads, from an average of 3.7 to 1.1 (P = 0.001). The stress leak-point pressure showed a significant increase, from an average of 68.1 to 93.5 cm H2O (P = 0.03). There was no relation between grade of incontinence and the success of the injection. Two cases suffered from temporary urinary retention. This study revealed that the transurethral submucosal collagen injection is an effective method for treating cases of intrinsic sphincteric deficiency. The volume of collagen required to produce the seal effect is small and it may decrease the reinjection rate. As experience is gained, the procedure time is typically 15 minutes. This makes it a reliable, cost-effective and well-controlled method. However, it has a learning curve and the cystoscope instruments require minor adaptation for its use.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657173     DOI: 10.1007/bf01900535

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  13 in total

1.  Stress Urinary Incontinence.

Authors:  E J McGuire; B Lytton; V Pepe; E I Kohorn
Journal:  Obstet Gynecol       Date:  1976-03       Impact factor: 7.661

2.  Treatment of urinary incontinence by the periurethral implantation of glutaraldehyde cross-linked collagen.

Authors:  L M Shortliffe; F S Freiha; R Kessler; T A Stamey; C E Constantinou
Journal:  J Urol       Date:  1989-03       Impact factor: 7.450

3.  Periurethral teflon injection for urinary incontinence.

Authors:  V A Politano; M P Small; J M Harper; C M Lynne
Journal:  J Urol       Date:  1974-02       Impact factor: 7.450

4.  Effect of abdominal pressure rise on the urethral profile. An experimental study on dogs.

Authors:  P Graber; G Laurent; E A Tanagho
Journal:  Invest Urol       Date:  1974-07

5.  Transurethral collagen injection for urinary incontinence.

Authors:  E J McGuire; R A Appell
Journal:  Urology       Date:  1994-04       Impact factor: 2.649

6.  Stress incontinence: classification and surgical approach.

Authors:  J G Blaivas; C A Olsson
Journal:  J Urol       Date:  1988-04       Impact factor: 7.450

7.  The treatment of urinary incontinence in children using glutaraldehyde cross-linked collagen.

Authors:  J Wan; E J McGuire; D A Bloom; M L Ritchey
Journal:  J Urol       Date:  1992-07       Impact factor: 7.450

8.  Migration and granulomatous reaction after periurethral injection of polytef (Teflon).

Authors:  A A Malizia; H M Reiman; R P Myers; J R Sande; S S Barham; R C Benson; M K Dewanjee; W J Utz
Journal:  JAMA       Date:  1984 Jun 22-29       Impact factor: 56.272

9.  Clinical assessment of urethral sphincter function.

Authors:  E J McGuire; C C Fitzpatrick; J Wan; D Bloom; J Sanvordenker; M Ritchey; E A Gormley
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

Review 10.  Collagen injection therapy for urinary incontinence.

Authors:  R A Appell
Journal:  Urol Clin North Am       Date:  1994-02       Impact factor: 2.241

View more
  3 in total

1.  Nonsurgical outpatient therapies for the management of female stress urinary incontinence: long-term effectiveness and durability.

Authors:  G Willy Davila
Journal:  Adv Urol       Date:  2011-06-23

2.  Urolastic for the treatment of women with stress urinary incontinence: 24-month follow-up.

Authors:  Janusz Zajda; Fawzy Farag
Journal:  Cent European J Urol       Date:  2015-09-26

3.  Safety and efficacy of polydimethylsiloxane (Macroplastique®) in women with stress urinary incontinence: analysis of data from patients who completed three years follow-up.

Authors:  Gamal Ghoniem; Bilal Farhan; Mashrin Lira Chowdhury; Yanjun Chen
Journal:  Int Urogynecol J       Date:  2021-06-08       Impact factor: 2.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.